PlainRecalls
FDA Drug Critical Class I Terminated

Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703; Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, India; NDC 16729-182-01.

Reported: September 19, 2018 Initiated: August 21, 2018 #D-1206-2018

Product Description

Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703; Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, India; NDC 16729-182-01.

Reason for Recall

Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.

Details

Recalling Firm
Accord Healthcare, Inc.
Units Affected
46,632 bottles
Distribution
Nationwide in the USA and Puerto Rico.
Location
Durham, NC

Frequently Asked Questions

What product was recalled?
Hydrochlorothiazide Tablets USP, 12.5 mg, 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703; Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad - 382 210, India; NDC 16729-182-01.. Recalled by Accord Healthcare, Inc.. Units affected: 46,632 bottles.
Why was this product recalled?
Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 19, 2018. Severity: Critical. Recall number: D-1206-2018.